ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

New research suggests that side effects from GLP-1 medications, including semaglutide and tirzepatide, extend beyond weight loss to include hair loss and nail problems. Studies compared users to controls, finding higher rates of these issues, prompting doctors to monitor patients carefully.
Tap to vote and see what everyone thinks.
Summary by ByteBrief